Showing results (1251-1260 of 1,376) with videos related to

Sort By:
Pageof 138
Biochemistry|July 2, 2021
Site-Specific Steric Control of SARS-CoV-2 Spike GlycosylationJoel D Allen, Himanshi Chawla, Firdaus Samsudin, et al.
Gut|December 15, 2010
Type of pain, pain-associated complications, quality of life, disability and resource utilisation in chronic pancreatitis: a prospective cohort studyDaniel K Mullady, Dhiraj Yadav, Stephen T Amann, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 29, 2017
Dengue Virus Evades AAV-Mediated Neutralizing Antibody Prophylaxis in Rhesus MonkeysDiogo M Magnani, Michael J Ricciardi, Varian K Bailey, et al.
Journal of Virology|September 8, 2017
Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue VaccineDiogo M Magnani, Cassia G T Silveira, Michael J Ricciardi, et al.
Journal of Virology|May 15, 2009
Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithmMelissa D Simek, Wasima Rida, Frances H Priddy, et al.
Science (New York, N.Y.)|August 20, 2016
Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virusJinyan Liu, Khader Ghneim, Devin Sok, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Dose-dependent regulation of immune memory responses against HIV by saponin monophosphoryl lipid A nanoparticle adjuvantParham Ramezani-Rad, Ester Marina-Zárate, Laura Maiorino, et al.
Nature|November 1, 2013
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeysDan H Barouch, James B Whitney, Brian Moldt, et al.
Cell Reports|July 8, 2025
Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic driftGe Song, Meng Yuan, Hejun Liu, et al.
Plos Pathogens|January 22, 2024
Potent antibody-dependent cellular cytotoxicity of a V2-specific antibody is not sufficient for protection of macaques against SIV challengeMichael W Grunst, Hwi Min Gil, Andres G Grandea, et al.
Pageof 138